Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Soudja SM"'
Autor:
Campisi L, Soudja SM, Cazareth J, Bassand D, Lazzari A, Brau F, Narni-Mancinelli E, Glaichenhaus N, Geissmann F, Lauvau G.
Publikováno v:
Eur J Immunol..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=erc_________::0eb807bb762939852d2bc73c8fcb97c7
Autor:
Apostolov AK; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France., Hamani M; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France., Hernandez-Vargas H; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France., Igalouzene R; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France., Guyennon A; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France., Fesneau O; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France., Marie JC; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France., Soudja SM; Tumor Escape Resistance Immunity Department, Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France saidi.soudja@inserm.fr.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2022 Jul 25; Vol. 6 (7), pp. 515-527. Date of Electronic Publication: 2022 Jul 25.
Autor:
Igalouzene R; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France., Hernandez-Vargas H; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France., Benech N; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France., Guyennon A; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France., Bauché D; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France., Barrachina C; Montpellier GenomiX, University of Montpellier, CNRS, INSERM, Montpellier, France., Dubois E; Montpellier GenomiX, University of Montpellier, CNRS, INSERM, Montpellier, France., Marie JC; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France., Soudja SM; Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2022 Apr 15; Vol. 132 (8).
Autor:
Lalle G; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Lautraite R; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Voisin A; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Twardowski J; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Stéphan P; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Perrin-Niquet M; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Igalouzene R; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Soudja SM; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Marie JC; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France., Vocanson M; CIRI-Centre International de Recherche en Infectiologie, INSERM, U1111, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France., De Silva N; Immunity and Cancer Department, Institut Curie, Paris-Sciences-Et-Lettres Research University, INSERM U932, Paris, France., Klein U; Division of Haematology and Immunology, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK., Ghosh S; Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA., Grinberg-Bleyer Y; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, Université Claude Bernard Lyon 1, Labex DEVweCAN, Centre Léon Bérard, Lyon, France. Yenkel.grinberg-bleyer@inserm.fr.
Publikováno v:
Scientific reports [Sci Rep] 2021 Oct 04; Vol. 11 (1), pp. 19674. Date of Electronic Publication: 2021 Oct 04.
Autor:
McCarron MJ; Department of Immunology Virology and Inflammation, Cancer Research Center of Lyon (CRCL) UMR INSERM1052, CNRS 5286 28 rue Laennec, F-69373 cedex 08, Lyon, France.; Université Lyon 1, F-69000, Lyon, France.; Centre Léon Bérard, Lyon, F-69008, Lyon, France.; Labex DEVweCAN F-69008, Lyon, France.; Genentech, South San Francisco, CA, 94080, USA., Irla M; Centre d'Immunologie de Marseille Luminy (CIML), INSERM U1104, CNRS UMR 7280, Aix-Marseille Université UM2, F-13288 cedex 09, Marseille, France., Sergé A; Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, INSERM U1068, CNRS UMR7258, Aix-Marseille Université UM105, 13273 cedex 09, Marseille, France., Soudja SM; Department of Immunology Virology and Inflammation, Cancer Research Center of Lyon (CRCL) UMR INSERM1052, CNRS 5286 28 rue Laennec, F-69373 cedex 08, Lyon, France.; Université Lyon 1, F-69000, Lyon, France.; Centre Léon Bérard, Lyon, F-69008, Lyon, France.; Labex DEVweCAN F-69008, Lyon, France., Marie JC; Department of Immunology Virology and Inflammation, Cancer Research Center of Lyon (CRCL) UMR INSERM1052, CNRS 5286 28 rue Laennec, F-69373 cedex 08, Lyon, France. julien.marie@inserm.fr.; Université Lyon 1, F-69000, Lyon, France. julien.marie@inserm.fr.; Centre Léon Bérard, Lyon, F-69008, Lyon, France. julien.marie@inserm.fr.; Labex DEVweCAN F-69008, Lyon, France. julien.marie@inserm.fr.
Publikováno v:
Nature communications [Nat Commun] 2019 Dec 19; Vol. 10 (1), pp. 5690. Date of Electronic Publication: 2019 Dec 19.
Autor:
Ruiz AL; 1] Cancer Research Center of Lyon UMR INSERM 1052 CNRS 5286, Immunology, Virology and Inflammation Department, 28 rue Laennec, F-69373 08 Lyon, France [2] LabEx DEVweCAN, F-69008 Lyon, France [3] Université Lyon 1, Lyon F-69008, France [4] Centre Léon Bérard, Lyon, F-69008 Lyon, France., Soudja SM; Albert Einstein College of Medicine of Yeshiva University, Microbiology and Immunology Department, Bronx, New York 10461, USA., Deceneux C; 1] Cancer Research Center of Lyon UMR INSERM 1052 CNRS 5286, Immunology, Virology and Inflammation Department, 28 rue Laennec, F-69373 08 Lyon, France [2] LabEx DEVweCAN, F-69008 Lyon, France [3] Université Lyon 1, Lyon F-69008, France [4] Centre Léon Bérard, Lyon, F-69008 Lyon, France., Lauvau G; Albert Einstein College of Medicine of Yeshiva University, Microbiology and Immunology Department, Bronx, New York 10461, USA., Marie JC; 1] Cancer Research Center of Lyon UMR INSERM 1052 CNRS 5286, Immunology, Virology and Inflammation Department, 28 rue Laennec, F-69373 08 Lyon, France [2] LabEx DEVweCAN, F-69008 Lyon, France [3] Université Lyon 1, Lyon F-69008, France [4] Centre Léon Bérard, Lyon, F-69008 Lyon, France [5] TGF-β and Immuno-Evasion Group, Immunology and Tumor Department, DKFZ German Cancer Research Center, Heidelberg 69121, Germany.
Publikováno v:
Nature communications [Nat Commun] 2014 Oct 06; Vol. 5, pp. 5150. Date of Electronic Publication: 2014 Oct 06.
Autor:
Lauvau G; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY 10461, USA. Electronic address: gregoire.lauvau@einstein.yu.edu., Chorro L; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY 10461, USA., Spaulding E; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY 10461, USA., Soudja SM; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY 10461, USA.
Publikováno v:
Cellular immunology [Cell Immunol] 2014 Sep-Oct; Vol. 291 (1-2), pp. 32-40. Date of Electronic Publication: 2014 Aug 14.
Autor:
Soudja SM; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Chandrabos C; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Yakob E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Veenstra M; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Palliser D; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Lauvau G; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Electronic address: gregoire.lauvau@einstein.yu.edu.
Publikováno v:
Immunity [Immunity] 2014 Jun 19; Vol. 40 (6), pp. 974-88. Date of Electronic Publication: 2014 Jun 12.
Autor:
Auphan-Anezin N; Centre d'Immunologie de Marseille-Luminy (CIML), Aix-Marseille Université UM2, Marseille, France. auphan@ciml.univ-mrs.fr, Verdeil G, Grange M, Soudja SM, Wehbe M, Buferne M, Mas A, Schmitt-Verhulst AM
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2013 Mar; Vol. 26 (2), pp. 167-75. Date of Electronic Publication: 2012 Dec 27.